Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4545195
Max Phase: Preclinical
Molecular Formula: C34H44ClN3O4
Molecular Weight: 594.20
Molecule Type: Unknown
Associated Items:
ID: ALA4545195
Max Phase: Preclinical
Molecular Formula: C34H44ClN3O4
Molecular Weight: 594.20
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCCN(CCC)C(=O)c1cc(Cl)cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC(C)(C)c2cccc(OC)c2)c1
Standard InChI: InChI=1S/C34H44ClN3O4/c1-6-16-38(17-7-2)33(41)26-19-25(20-28(35)21-26)32(40)37-30(18-24-12-9-8-10-13-24)31(39)23-36-34(3,4)27-14-11-15-29(22-27)42-5/h8-15,19-22,30-31,36,39H,6-7,16-18,23H2,1-5H3,(H,37,40)/t30-,31+/m0/s1
Standard InChI Key: MZZICJGCOVKCKO-IOWSJCHKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 594.20 | Molecular Weight (Monoisotopic): 593.3020 | AlogP: 5.84 | #Rotatable Bonds: 15 |
Polar Surface Area: 90.90 | Molecular Species: BASE | HBA: 5 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 13.82 | CX Basic pKa: 8.85 | CX LogP: 6.05 | CX LogD: 4.59 |
Aromatic Rings: 3 | Heavy Atoms: 42 | QED Weighted: 0.21 | Np Likeness Score: -0.88 |
1. Zogota R, Kinena L, Withers-Martinez C, Blackman MJ, Bobrovs R, Pantelejevs T, Kanepe-Lapsa I, Ozola V, Jaudzems K, Suna E, Jirgensons A.. (2019) Peptidomimetic plasmepsin inhibitors with potent anti-malarial activity and selectivity against cathepsin D., 163 [PMID:30529637] [10.1016/j.ejmech.2018.11.068] |
Source(1):